C07F 9/65397
Having the two nitrogen atoms in positions 1 and 3
Official title: {having the two nitrogen atoms in positions 1 and 3}
C07F9/65397 (Having the two nitrogen atoms in positions 1 and 3) appears on 23 US grants and 16 published applications in this corpus.
Search patents in C07F- Granted patents
- 23
- Published applications
- 16
- Assignees
- 18
- Inventors
- 54
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 2 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 3 | 2 |
| 2015 | 2 | 2 |
| 2016 | 5 | 1 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 3 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 3 |
| 2024 | 1 | 1 |
| 2025 | 1 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Thiadiazolone derivatives and their use as AMPK agonists for the treatment of diabetes and related disorders2 Jun 2026US 12,643,918 B2Betagenon AB
- CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker13 May 2025US 12,297,222 B2Navidea Biopharmaceuticals, Inc.
- CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker11 Jun 2024US 12,006,339 B2Navidea Biopharmaceuticals, Inc.
- Process for preparing ceftaroline fosamil31 Dec 2019US RE47,787 E1Sandoz Ltd.
- Methods for the safe administration of imidazole or imidazolium compounds8 Jan 2019US 10,173,986 B2Antecip Bioventures II LLC
- Cd206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker5 Sep 2024US 2024/0294564 A1Navidea Biopharmaceuticals, Inc.
- Thiadiazolone derivatives and their use as ampk agonists for the treatment of diabetes and related disorders30 Nov 2023US 2023/0382930 A1Betagenon Bio AB
- Cd206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker23 Nov 2023US 2023/0374055 A1Navidea Biopharmaceuticals, Inc.
- Protein tyrosine phosphatase inhibitors and methods of use thereof19 Jan 2023US 2023/0019236 A1AbbVie Inc.
- Dosage forms for oral administration of zoledronic acid or related compounds for treating disease24 Jan 2019US 2019/0023661 A1Antecip Bioventures II LLC
Most cited
By later US patents
- Substituted imidazolium compounds for treating disease97US 8,901,162 B1Antecip Bioventures II LLC · 2014
- Substituted imidazolium compounds for treating disease94US 8,835,650 B1Antecip Bioventures II LLC · 2014
- Substituted imidazolium compounds for treating disease82US 9,006,279 B1Antecip Bioventures II LLC · 2015
- Methods for the safe administration of imidazole or imidazolium compounds9US 10,173,986 B2Antecip Bioventures II LLC · 2019
- Phosphoramidate alkylator prodrugs8US 8,507,464 B2Threshold Pharmaceuticals, Inc. · 2013